Professional
Added to YB: 2024-08-13
Pitch date: 2024-07-01
DVYSR.ST [bullish]
Devyser Diagnostics AB (publ)
+6.67%
current return
Author Info
No bio for this author
Company Info
Devyser Diagnostics AB (publ) engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
Market Cap
SEK 2.3B
Pitch Price
SEK 112.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-175.28
P/E
-49.91
EV/Sales
9.54
Sector
Biotechnology
Category
growth
Protean Funds Scandinavia AB Portfolio Holding: Devyser Diagnostics AB
DVYSR.ST: Devyser Diagnostics AB momentum builds with largest order yet. Thermo Fisher global rights deal for post-transplant products. Organic sales growth acceleration expected H2, driving profitability. Recent order streak signals positive outlook.
Read full article (1 min)